Patricia A. Bradford, Director at Phio Pharmaceuticals Corp. (PHIO), bought 6,500 shares at $1.01 ($7K) on 2026-09-24, disclosed to the SEC on 2026-09-25.
Open-market purchase of $7k PHIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |